If lymph node involvement is confirmed in the affected individual undergoing neoadjuvant therapy that is a possible prospect for qualified axillary dissection (TAD), a marker needs to be inserted from the lymph node after biopsy.one Công d?ng n?i b?t c?a Back Tumor h? tr? ?i?u tr? u x? t? cung, u vú lành tínhThis investigation or therapeutic in